Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+9.0%
5Y CAGR+32.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+9.0%/yr
vs +4.7%/yr prior
5Y CAGR
+32.6%/yr
Recent deceleration
Acceleration
+4.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $328.17M | +7.8% |
| 2024 | $304.43M | +1.7% |
| 2023 | $299.32M | +18.2% |
| 2022 | $253.28M | +194.5% |
| 2021 | $86.00M | +7.5% |
| 2020 | $79.97M | -63.3% |
| 2019 | $218.06M | +3.3% |
| 2018 | $211.06M | +3.2% |
| 2017 | $204.46M | +3.9% |
| 2016 | $196.69M | - |